Profile
| Role | Director |
|---|---|
| Notability | 30/100 |
Board memberships
- Emergent BioSolutions Inc.
Updated Jul 16, 2026
DeGolyer Donald W has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $471K.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-04 | EBS | Emergent BioSolutions Inc. | S — Open-market sale | 954 | $8.96 | $9K |
| 2026-05-04 | EBS | Emergent BioSolutions Inc. | S — Open-market sale | 14.5K | $8.36 | $121K |
| 2026-05-04 | EBS | Emergent BioSolutions Inc. | A — Grant or award | 25.3K | $0.00 | |
| 2025-08-12 | EBS | Emergent BioSolutions Inc. | S — Open-market sale | 7.8K | $8.65 | $68K |
| 2024-11-14 | EBS | Emergent BioSolutions Inc. | S — Open-market sale | 25.0K | $10.91 | $273K |
DeGolyer Donald W is a corporate insider — currently tracked as Director of Emergent BioSolutions Inc. (EBS). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($471K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live DeGolyer Donald W profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.